Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Inhalational Anesthesia Drugs Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Inhalational Anesthesia Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Inhalational Anesthesia Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Inhalational Anesthesia Drugs Market Size Growth Rate by Type
    • 1.4.2 Sevoflurane
    • 1.4.3 Desflurane
    • 1.4.4 Isoflurane
    • 1.4.5 Enflurane
  • 1.5 Market by Application
    • 1.5.1 Global Inhalational Anesthesia Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Ambulatory Surgical Centers
  • 1.6 Coronavirus Disease 2019 (Covid-19): Inhalational Anesthesia Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Inhalational Anesthesia Drugs Industry
      • 1.6.1.1 Inhalational Anesthesia Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Inhalational Anesthesia Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Inhalational Anesthesia Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Inhalational Anesthesia Drugs Market Size Estimates and Forecasts
    • 2.1.1 Global Inhalational Anesthesia Drugs Revenue 2015-2026
    • 2.1.2 Global Inhalational Anesthesia Drugs Sales 2015-2026
  • 2.2 Inhalational Anesthesia Drugs Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Inhalational Anesthesia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Inhalational Anesthesia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Inhalational Anesthesia Drugs Competitor Landscape by Players

  • 3.1 Inhalational Anesthesia Drugs Sales by Manufacturers
    • 3.1.1 Inhalational Anesthesia Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Inhalational Anesthesia Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Inhalational Anesthesia Drugs Revenue by Manufacturers
    • 3.2.1 Inhalational Anesthesia Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Inhalational Anesthesia Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Inhalational Anesthesia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Inhalational Anesthesia Drugs Revenue in 2019
    • 3.2.5 Global Inhalational Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Inhalational Anesthesia Drugs Price by Manufacturers
  • 3.4 Inhalational Anesthesia Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Inhalational Anesthesia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Inhalational Anesthesia Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Inhalational Anesthesia Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Inhalational Anesthesia Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Inhalational Anesthesia Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Inhalational Anesthesia Drugs Revenue by Type (2015-2020)
    • 4.1.3 Inhalational Anesthesia Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Inhalational Anesthesia Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Inhalational Anesthesia Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Inhalational Anesthesia Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Inhalational Anesthesia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Inhalational Anesthesia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Inhalational Anesthesia Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Inhalational Anesthesia Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Inhalational Anesthesia Drugs Revenue by Application (2015-2020)
    • 5.1.3 Inhalational Anesthesia Drugs Price by Application (2015-2020)
  • 5.2 Inhalational Anesthesia Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Inhalational Anesthesia Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Inhalational Anesthesia Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Inhalational Anesthesia Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Inhalational Anesthesia Drugs by Country
    • 6.1.1 North America Inhalational Anesthesia Drugs Sales by Country
    • 6.1.2 North America Inhalational Anesthesia Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Inhalational Anesthesia Drugs Market Facts & Figures by Type
  • 6.3 North America Inhalational Anesthesia Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Inhalational Anesthesia Drugs by Country
    • 7.1.1 Europe Inhalational Anesthesia Drugs Sales by Country
    • 7.1.2 Europe Inhalational Anesthesia Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Inhalational Anesthesia Drugs Market Facts & Figures by Type
  • 7.3 Europe Inhalational Anesthesia Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Inhalational Anesthesia Drugs by Region
    • 8.1.1 Asia Pacific Inhalational Anesthesia Drugs Sales by Region
    • 8.1.2 Asia Pacific Inhalational Anesthesia Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Inhalational Anesthesia Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Inhalational Anesthesia Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Inhalational Anesthesia Drugs by Country
    • 9.1.1 Latin America Inhalational Anesthesia Drugs Sales by Country
    • 9.1.2 Latin America Inhalational Anesthesia Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Inhalational Anesthesia Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Inhalational Anesthesia Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Inhalational Anesthesia Drugs by Country
    • 10.1.1 Middle East and Africa Inhalational Anesthesia Drugs Sales by Country
    • 10.1.2 Middle East and Africa Inhalational Anesthesia Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Inhalational Anesthesia Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Inhalational Anesthesia Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Baxter
    • 11.1.1 Baxter Corporation Information
    • 11.1.2 Baxter Description, Business Overview and Total Revenue
    • 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Baxter Inhalational Anesthesia Drugs Products Offered
    • 11.1.5 Baxter Recent Development
  • 11.2 AbbVie
    • 11.2.1 AbbVie Corporation Information
    • 11.2.2 AbbVie Description, Business Overview and Total Revenue
    • 11.2.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 AbbVie Inhalational Anesthesia Drugs Products Offered
    • 11.2.5 AbbVie Recent Development
  • 11.3 Piramal Enterprises
    • 11.3.1 Piramal Enterprises Corporation Information
    • 11.3.2 Piramal Enterprises Description, Business Overview and Total Revenue
    • 11.3.3 Piramal Enterprises Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Piramal Enterprises Inhalational Anesthesia Drugs Products Offered
    • 11.3.5 Piramal Enterprises Recent Development
  • 11.4 Halocarbon Products
    • 11.4.1 Halocarbon Products Corporation Information
    • 11.4.2 Halocarbon Products Description, Business Overview and Total Revenue
    • 11.4.3 Halocarbon Products Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Halocarbon Products Inhalational Anesthesia Drugs Products Offered
    • 11.4.5 Halocarbon Products Recent Development
  • 11.5 Jiangsu Hengrui Medicine
    • 11.5.1 Jiangsu Hengrui Medicine Corporation Information
    • 11.5.2 Jiangsu Hengrui Medicine Description, Business Overview and Total Revenue
    • 11.5.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Products Offered
    • 11.5.5 Jiangsu Hengrui Medicine Recent Development
  • 11.6 Fresenius Kabi
    • 11.6.1 Fresenius Kabi Corporation Information
    • 11.6.2 Fresenius Kabi Description, Business Overview and Total Revenue
    • 11.6.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Fresenius Kabi Inhalational Anesthesia Drugs Products Offered
    • 11.6.5 Fresenius Kabi Recent Development
  • 11.1 Baxter
    • 11.1.1 Baxter Corporation Information
    • 11.1.2 Baxter Description, Business Overview and Total Revenue
    • 11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Baxter Inhalational Anesthesia Drugs Products Offered
    • 11.1.5 Baxter Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Inhalational Anesthesia Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Inhalational Anesthesia Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Inhalational Anesthesia Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Inhalational Anesthesia Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Inhalational Anesthesia Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Inhalational Anesthesia Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Inhalational Anesthesia Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Inhalational Anesthesia Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Inhalational Anesthesia Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Inhalational Anesthesia Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Inhalational Anesthesia Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Inhalational Anesthesia Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Inhalational Anesthesia Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Inhalational Anesthesia Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Inhalational Anesthesia Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Inhalational Anesthesia Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Inhalational Anesthesia Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Inhalational Anesthesia Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Inhalational Anesthesia Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Inhalational Anesthesia Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Inhalational Anesthesia Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Inhalational Anesthesia Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Inhalational Anesthesia Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Inhalational Anesthesia Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Inhalational Anesthesia Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Inhalational Anesthesia Drugs market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Inhalational Anesthesia Drugs industry.
    Based on our recent survey, we have several different scenarios about the Inhalational Anesthesia Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Inhalational Anesthesia Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inhalational Anesthesia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inhalational Anesthesia Drugs market in terms of both revenue and volume.
    Players, stakeholders, and other participants in the global Inhalational Anesthesia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Sales and Pricing Analyses
    Readers are provided with deeper sales analysis and pricing analysis for the global Inhalational Anesthesia Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
    In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Inhalational Anesthesia Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Inhalational Anesthesia Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inhalational Anesthesia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inhalational Anesthesia Drugs market.
    The following manufacturers are covered in this report:
    Baxter
    AbbVie
    Piramal Enterprises
    Halocarbon Products
    Jiangsu Hengrui Medicine
    Fresenius Kabi
    ...
    Inhalational Anesthesia Drugs Breakdown Data by Type
    Sevoflurane
    Desflurane
    Isoflurane
    Enflurane
    Inhalational Anesthesia Drugs Breakdown Data by Application
    Hospitals
    Clinics
    Ambulatory Surgical Centers

    Buy now